A detailed history of Concourse Financial Group Securities, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,000 shares of SAGE stock, worth $5,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$5,440
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$18.62 - $26.95 $18 - $26
-1 Reduced 0.1%
1,000 $18,000
Q3 2023

Oct 25, 2023

BUY
$16.75 - $48.98 $16,766 - $49,028
1,001 New
1,001 $20,000
Q2 2023

Aug 10, 2023

BUY
$40.65 - $59.54 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$37.27 - $46.57 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$32.2 - $43.61 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$32.28 - $43.27 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$27.52 - $37.99 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$30.71 - $45.71 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$37.06 - $47.11 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$40.26 - $57.37 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$54.88 - $79.29 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$70.65 - $96.76 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$58.41 - $89.06 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$41.13 - $62.45 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$25.95 - $43.15 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020

SELL
$26.15 - $77.24 $2,431 - $7,183
-93 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$60.18 - $154.77 $1,083 - $2,785
18 Added 24.0%
93 $7,000
Q3 2019

Nov 13, 2019

SELL
$140.29 - $189.96 $2,805 - $3,799
-20 Reduced 21.05%
75 $11,000
Q2 2019

Aug 13, 2019

SELL
$157.85 - $183.09 $1,262 - $1,464
-8 Reduced 7.77%
95 $17,000
Q1 2019

May 15, 2019

BUY
$89.33 - $163.65 $89 - $163
1 Added 0.98%
103 $16,000
Q3 2018

Nov 13, 2018

BUY
$138.11 - $169.04 $14,087 - $17,242
102 New
102 $14,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.